HOGA1 and Insulin resistance: Hoga1 ASO treatment ameliorated the clinical indexes of insulin resistance including glucose, insulin, and homeostatic model assessment of insulin resistance (HOMA-IR) levels in HFD-induced mice (Figure 7).